Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551]
Bioorg Med Chem Lett
.
2021 Oct 1:49:128262.
doi: 10.1016/j.bmcl.2021.128262.
Epub 2021 Aug 2.
Authors
Ulrich Grädler
1
,
Michael Busch
2
,
Birgitta Leuthner
2
,
Michael Raba
3
,
Lars Burgdorf
2
,
Martin Lehmann
2
,
Nina Linde
2
,
Christina Esdar
2
Affiliations
1
Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany. Electronic address: ulrich.graedler@merckgroup.com.
2
Merck KGaA, Frankfurter Str. 250, D-64293 Darmstadt, Germany.
3
Crelux GmbH - a WuXi AppTec Company, Am Klopferspitz 19 a, D-82152 München, Germany.
PMID:
34352662
DOI:
10.1016/j.bmcl.2021.128262
No abstract available
Publication types
Published Erratum